Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Ophthalmic Viscoelastic Devices Market Set To Climb From $2.85 Billion In 2026 To $3.47 Billion By 2030
The ophthalmic viscoelastic devices market has demonstrated consistent growth in recent years. This market is expected to expand from $2.72 billion in 2025 to $2.85 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.7%. Historically, this expansion has been driven by the increasing prevalence of cataract surgeries, a growing aging population, the rising adoption of intraocular surgical procedures, the expansion of ophthalmology clinics, and improved access to eye care services.
The ophthalmic viscoelastic devices market size is predicted to undergo substantial growth in the forthcoming years. It is set to expand to $3.47 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 5.1%. This expansion during the forecast period can be attributed to a rising demand for high-quality ophthalmic surgical outcomes, a heightened focus on reducing complications, the proliferation of advanced ophthalmic surgery centers, increasing investments in eye care infrastructure, and the growing adoption of innovative viscoelastic materials. Prominent trends for the forecast period include the increasing uptake of advanced viscoelastic formulations, a rising demand for dual-property OVDs, a growing emphasis on enhanced tissue protection, the expansion of minimally invasive ophthalmic surgeries, and improvements in shelf stability and biocompatibility profiles.
Get A Free Sample Report With In-Depth Market Insights:
Ophthalmic Viscoelastic Devices Market Expansion Drivers: What’s Shaping Future Growth?
The increasing volume of ophthalmic surgeries is anticipated to drive expansion in the ophthalmic viscoelastic devices market moving ahead. These eye operations involve diverse procedures such as cataract surgery, corneal transplants, and retinal detachment repair. Ophthalmic viscoelastic devices (OVDs) are employed during these surgeries to help maintain anatomical space, safeguard sensitive ocular structures, aid surgical handling, and provide clear visibility, thanks to their viscous and elastic characteristics. This contributes to improved surgical results and minimizes issues like tissue damage and complications during the procedure. For example, data from May 2023, provided by the National Health Service England, a publicly funded healthcare system in the UK, indicated that cataract surgery accounts for 6% of all annual surgeries, with more than 450,000 such procedures carried out. Forecasts suggest an approximate 25% rise by 2027 and a significant 50% increase by 2035 in the volume of cataract surgeries. Consequently, the expanding number of ophthalmic surgeries is fueling the expansion of the ophthalmic viscoelastic devices market.
Ophthalmic Viscoelastic Devices Market Segments: Where Is Growth Concentrated?
The ophthalmic viscoelastic devices market covered in this report is segmented –
1) By Product Type: Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic
2) By Application: Cataract Surgery, Glaucoma Surgery, Corneal Transplant, Vitreoretinal Surgery
3) By End User: Hospital, Ophthalmology Clinics, Other End-Users
Subsegments:
1) By Cohesive Ophthalmic Viscoelastic: Sodium Hyaluronate, Hyaluronic Acid
2) By Dispersive Ophthalmic Viscoelastic: Sodium Chondroitin Sulfate, Dispersive Hydrogel
Ophthalmic Viscoelastic Devices Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies in the ophthalmic viscoelastic devices market are prioritizing technological advancements, such as line implant-free system solutions, to boost surgical precision and patient outcomes in eye surgeries. An advanced line implant-free system represents an innovative technology that streamlines medical procedures without requiring invasive implants, offering non-intrusive alternatives for various treatments and interventions. For example, in April 2023, Bausch + Lomb Corporation, a US-based eye health company, introduced the StableVisc cohesive ophthalmic viscosurgical device (OVD) and the TotalVisc Viscoelastic System. StableVisc, a cohesive OVD, assists in maintaining space within the anterior chamber of the eye, enabling surgeons to extract and replace the clouded natural lens. The TotalVisc Viscoelastic System, which includes both StableVisc and ClearVisc, a dispersive OVD, offers protection to ocular tissue during the surgical procedure. These products are formulated with sodium hyaluronate and sorbitol, a unique chemical compound that laboratory research indicates provides enhanced free radical scavenging properties when compared to other OVDs. TotalVisc OVD delivers dual-action mechanical and chemical protection.
Ophthalmic Viscoelastic Devices Market Leading Companies And Competitive Benchmarking
Major companies operating in the ophthalmic viscoelastic devices market are Altacor Ltd., Bausch Health Companies Inc., Bohus Biotech AB, Carl Zeiss Meditec AG, Haohai Biological Technology Co. Ltd., Johnson & Johnson Pvt. Ltd., Novartis International AG, Rumex International Corporation, Rayner Intraocular Lenses Limited, Aurolab, Alcon Inc., Beaver-Visitec International, Neu Micromed International Pvt. Ltd., Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., Croma Pharma GmbH, Medicontur Medical Engineering Ltd., Rhein Medical Inc., MicroSurgical Technology, FCI Ophthalmics Inc., Hanita Lenses Ltd., HOYA Medical Singapore Pte. Ltd.
View The Full Ophthalmic Viscoelastic Devices Market Report:
Ophthalmic Viscoelastic Devices Market Largest Region By Revenue And Market Share
North America was the largest region in the ophthalmic viscoelastic devices market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global ophthalmic viscoelastic devices market report during the forecast period. The regions covered in the ophthalmic viscoelastic devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
